NCT05305053

Brief Summary

Preoperative multidisciplinary team (MDT)discussions are recommended by national and international guidelines. However, no guidance is given on how to organise and execute an MDT discussion. The objective of this study is to describe the methods used for preoperative MDT discussion executed in the Netherlands.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
225

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2022

Typical duration for all trials

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 18, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 31, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

June 12, 2024

Status Verified

June 1, 2024

Enrollment Period

2.2 years

First QC Date

January 18, 2022

Last Update Submit

June 10, 2024

Conditions

Keywords

high-risk;preoperative risk predictionperioperative mortalityMultidisciplinary Team meeting

Outcome Measures

Primary Outcomes (3)

  • Attendance of the MDT

    number of carers present at meeting

    1-4-2022 untill 1-10-2022

  • Decisions made in MDT

    number of decisions made

    01-04-2022 untill 01-010-2022

  • 12 months postoperative mortality or post MDT

    number of patients that died within 12 months postoperative or 12 months post MDT

    01-04-2022 untill 01-10-2024

Secondary Outcomes (3)

  • 30 day postoperative mortality or post MDT

    01-04-2022 untill 01-10-2022

  • Serious adverse events at 12 months postoperative or post MDT

    01-04-2022 untill 01-10-2024

  • Hospital admissions at 12 months postoperative or post MDT

    01-04-2022 untill 01-10-2024

Study Arms (1)

high-risk noncardiac surgery patients for preoperative Multidisciplinary Team (MDT) discussion

observation of MDT in 11 hospitals

Other: preoperative MDT discussion

Interventions

high-risk patients are subjected to an MDT discussion among care providers

high-risk noncardiac surgery patients for preoperative Multidisciplinary Team (MDT) discussion

Eligibility Criteria

Age16 Years - 100 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All high risk noncardiac surgical patients selected for a preoperative MDT discussion.

You may qualify if:

  • \* All patients selected for a Multidisciplinary Team discussion

You may not qualify if:

  • \* No implicit consent given for scientific research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Rijnstate Hospital

Arnhem, Gelderland, 6800 TA, Netherlands

Location

Gelderse Vallei

Ede, Gelderland, 6716RP, Netherlands

Location

Catharina Ziekenhuis

Eindhoven, North Brabant, Netherlands

Location

MC Leeuwarden

Leeuwarden, Provincie Friesland, Netherlands

Location

Amsterdam University Medical Centre location VU

Amsterdam, South Holland, 1081HV, Netherlands

Location

LUMC

Leiden, South Holland, Netherlands

Location

Maasstad Ziekenhuis

Rotterdam, South Holland, 3079DZ, Netherlands

Location

Franciscus Gasthuis

Rotterdam, South Holland, Netherlands

Location

UMCU

Utrecht, Netherlands

Location

MeSH Terms

Conditions

Frailty

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jacqueline M Vernooij, MD

    Rijnstate

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 18, 2022

First Posted

March 31, 2022

Study Start

April 1, 2022

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

June 12, 2024

Record last verified: 2024-06

Locations